首页 | 本学科首页   官方微博 | 高级检索  
     


Cancer and Rheumatoid Arthritis
Affiliation:1. Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Unit 1444, 1515 Holcombe Boulevard, Houston, TX 77030, USA;2. Department of General Internal Medicine, Section of Rheumatology and Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;1. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Department of Medicine, University of Oklahoma Health Sciences Center, MS 38, 825 Northeast 13th Street, Oklahoma City, OK 73104, USA;2. Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Departments of Medicine and Pathology, University of Oklahoma Health Sciences Center, MS 38, 825 Northeast 13th Street, Oklahoma City, OK 73104, USA;3. The Metrohealth System, Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, USA;4. US Department of Veterans Affairs, Oklahoma City, OK, USA;1. AP-HP, Hôpital Saint Antoine, service de médecine interne et Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Faculté de Médecine Sorbonne Université, F-75012, Paris, France;2. Sorbonne Universités, UPMC Université Paris 06, UMR 7211, Département Hospitalo-Universitaire Inflammation-Immunopathologie-Biotherapie (DHU i2B), F-75005, Paris, France;3. Unité Epidémiologie et Biostatistiques, INSERM, Hôpital Saint Louis, Paris, France;4. INSERM, UMR_S 959, F-75013, Paris, France;5. CNRS, FRE3632, F-75005, Paris, France;6. AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Département de Médecine Interne et Immunologie Clinique, National center for Autoimmune and Systemic rare disease, National center for Autoinflammatory diseases and amyloidosis, F-75013, Paris, France;7. Division of Rheumatology, Azienda USL-IRCCS di Reggio Emilia, Università di Modena e Reggio Emilia, Reggio Emilia Italy;8. Service de médecine Vasculaire, hôpital st Andre, 1 rue Jean burguet, 33075 Bordeaux, France;9. Department of Internal Medicine, CHU Purpan, UMR 152 Pharma Dev, IRD Toulouse 3 University, France;10. Service de Médecine Interne, CHU Rennes, Rennes, France;11. Service de Médecine interne Centre Hospitalier de Bigorre Boulevard de Lattre de Tassigny 65013 TARBES Cedex 9, France;12. Inserm UMR_1109, Fédération de Médecine Translationnelle, Université de Strasbourg, Service de rhumatologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France;13. AP-HP, Hôpital Avicenne, service de médecine interne, Université Paris 13, 93000, Bobigny, France;14. Service de médecine interne, hôpital Haut-Lévêque, 33600 Pessac, France;15. Pediatric rheumatology, APHP, CHU Bicêtre, 78, Rue Gal. Leclerc, 94275, Le Kremlin-Bicêtre, France;p. CeRéMAIA- French reference center for auto-inflammatory diseases and inflammatory amyloidosis, 94270, Le Kremlin Bicêtre, France;q. Service de médecine interne, Hôpital Poitiers, CHU Poitiers, France;r. Service de médecine interne, Hôpital Angers, CHU Angers, France;s. AP-HP, Hôpital Saint Louis, service de médecine interne, Université Paris 7, Paris, France;t. Service de médecine interne, Hôpital Joseph Ducuing, 15, rue de Varsovie BP 53160, 31027 Toulouse Cedex 3, France;u. CHU Clermont-Ferrand, Service Médecine Interne, CHU Estaing, F-63003 Clermont-Ferrand, France;v. Université Clermont Auvergne, CNRS-UMR 6602, Institut Pascal, Axe TGI (gpe. PEPRADE), F-63000 Clermont-Ferrand, France;w. Service de Médecine Interne Hôpital Bichat, APHP, Paris, France
Abstract:
Keywords:Cancer  Rheumatoid arthritis  Disease-modifying antirheumatic drugs  Biologic therapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号